VSBC
VITASPRING BIOMEDICAL CO. LTD.Company Information
- Company Name
- VITASPRING BIOMEDICAL CO. LTD.
- CIK
- CIK0001697884
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- VSBC: OTC
- Fiscal Year End
- January 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8731
- SIC Description
- Services-Commercial Physical & Biological Research
- Ticker
- VSBC
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-09-17
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Receivable Net Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Deposits Assets Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Receivables Net Current | - | - | - | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deposits Assets Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Accounts Payable Current | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | - | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 2 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | ||||||
| Accounts Payable Other Current | - | - | 1 | 1 | 1 | - | - | - | - | - | - | 0 | ||||||
| Other Liabilities Current | - | 1 | - | - | - | 1 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Accrued Income Taxes Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Liabilities | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | - | 3 | 3 | ||||||
| Commitments And Contingencies | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -5 | -5 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -3 | -3 | ||||||
| Additional Paid In Capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Retained Earnings Accumulated Deficit | -6 | -6 | -6 | -6 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -4 | ||||||
| Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | 500 | ||||||
| Common Stock Shares Issued | 207 | 207 | 207 | 207 | 207 | 207 | 207 | 207 | 207 | 207 | 207 | 207 | ||||||
| Allowance For Doubtful Accounts Receivable Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Shares Outstanding | 207 | 207 | 207 | 207 | 207 | - | - | - | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialVITASPRING BIOMEDICAL CO. LTD. (VSBC) — SEC Financial Statements & Analysis
VITASPRING BIOMEDICAL CO. LTD. (VSBC) is a services-commercial physical & biological research company, incorporated in NV. VITASPRING BIOMEDICAL CO. LTD. trades on OTC as: VSBC. VITASPRING BIOMEDICAL CO. LTD. (VSBC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-07-31, filed with the SEC on 2026-09-17. Based on that filing, VITASPRING BIOMEDICAL CO. LTD. carries a market cap of $2.30M, a P/E ratio of -5.04x, a P/B ratio of -0.49x, a P/S ratio of -2223.14x, an enterprise value of $2.28M, and an EV/EBITDA multiple of -5.16x. On profitability, it posts an operating margin of 339.36%, a net margin of 339.05%, a Return on Equity (ROE) of 10.28%, and a Return on Assets (ROA) of -2861.90%. Per share, it reports EPS of $-0.00, diluted EPS of $-0.00, free cash flow per share of $0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -14.16% year-over-year, and EPS growth of -14.16% year-over-year. On the balance sheet, it maintains a current ratio of 0.01x, a quick ratio of 0.01x, working capital of $-2.25M, a debt-to-equity ratio of -1.00x, a debt ratio of 315.55, free cash flow of $10.57K (TTM), and net debt of $-13.37K. Figures sourced from SEC EDGAR.
- Market Cap
- $2.30M
- P/E TTM
- -5.04x
- EPS TTM
- $-0.00
- P/B TTM
- -0.49x
- ROE TTM
- 10.28%
- ROA TTM
- -2861.90%
- Debt To Equity
- -1.00x
- Free Cash Flow TTM
- $10.57K
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-07-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is VITASPRING BIOMEDICAL CO. LTD. in?
VITASPRING BIOMEDICAL CO. LTD. (VSBC) operates in the Services-Commercial Physical & Biological Research industry.
What exchange does VSBC trade on?
VITASPRING BIOMEDICAL CO. LTD. (VSBC) trades on the OTC.
Where is VITASPRING BIOMEDICAL CO. LTD. incorporated?
VITASPRING BIOMEDICAL CO. LTD. is incorporated in NV.
When was VITASPRING BIOMEDICAL CO. LTD. (VSBC)'s most recent SEC filing?
VITASPRING BIOMEDICAL CO. LTD. (VSBC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-07-31, filed with the SEC on 2026-09-17.
What is VSBC's market cap?
VITASPRING BIOMEDICAL CO. LTD. (VSBC) has a market capitalization of $2.30M as of 2026-07-31.
What is VSBC's EPS (earnings per share)?
VITASPRING BIOMEDICAL CO. LTD. (VSBC)'s trailing twelve month EPS is $-0.00 as of 2026-07-31.
What is VSBC's ROE (return on equity)?
VITASPRING BIOMEDICAL CO. LTD. (VSBC)'s trailing twelve month Return on Equity (ROE) is 10.28% as of 2026-07-31.
What is VSBC's ROA (return on assets)?
VITASPRING BIOMEDICAL CO. LTD. (VSBC)'s trailing twelve month Return on Assets (ROA) is -2861.90% as of 2026-07-31.
What is VSBC's EV/EBITDA?
VITASPRING BIOMEDICAL CO. LTD. (VSBC)'s trailing twelve month EV/EBITDA is -5.16x as of 2026-07-31.